Teva Pharmaceutical Industries reported a slightly larger than expected rise in fourth-quarter profit, helped by double-digit sales gains in a trio of its branded drugs to treat migraines, Huntington’s disease and schizophrenia.
Matino discussed data from the phase 3 BASIS study evaluating the recently approved Hympavzi.
Regulators approved controversial therapies amid excess deaths, questionable efficacy, and conflicts of interest.
Background Caregivers of people with motor neuron disease (MND) face more negative consequences of caregiving than other terminal illnesses. The impact of this caregiver burden…
One person is in custody following a “weapons complaint” at the QEII hospital in Halifax, according to police.
This research challenges numerous assumptions about large-scale monoculture agriculture and how it was thought to be impossible in the Amazon.
The shocking collision took place as the American Airlines flight carrying 64 people made its final approach to Ronald Reagan Washington National Airport shortly before 9pm…
RFK Jr.’s confirmation hearings continue today as he appears before a second Senate committee. Follow STAT’s live updates.
Background The immature lungs of very preterm infants are exposed to supraphysiologic oxygen, contributing to bronchopulmonary dysplasia (BPD), a chronic lung disease that is the…
Wearable technology is transforming mental health care by linking circadian rhythm disruptions to mood disorders like depression
Still’s disease, a systemic autoinflammatory disorder with a classic multigenetic background, is characterised by polyarthritis, high-spiking fever, salmon-like evanescent skin rash, and hyperferritinaemia. Although the…
